Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias
2017 · Neurobiology of Disease · 47 citations
https://doi.org/10.1016/j.nbd.2017.08.001
J
Jennifer Stanic
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
695
Citations
13
h-index
16
i10-index
Jennifer Stanic is an academic researcher from University of Wisconsin–Madison. The author has contributed to research in topics: Neuroscience and Neuropharmacology Research & Neuroinflammation and Neurodegeneration Mechanisms & Neurotransmitter Receptor Influence on Behavior. The author has an h-index of 13, co-authored 20 publications.
ORCID: 0000-0003-1295-4568Papers by this author
worksMissense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder
2023 · Genetics in Medicine · 15 citations
https://doi.org/10.1016/j.gim.2023.100922
LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias
2016 · Molecular Brain · 13 citations
https://doi.org/10.1186/s13041-016-0234-2
GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice
2021 · Brain Behavior and Immunity · 10 citations
https://doi.org/10.1016/j.bbi.2021.07.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat